Cardiac Surgery Instruments Market To Reach $5.36 Billion By 2033

Cardiac Surgery Instruments Market Growth & Trends

The global cardiac surgery instruments market size is estimated to reach USD 5.36 billion by 2033, registering to grow at a CAGR of 7.56% from 2025 to 2033 according to a new report by Grand View Research, Inc. Increase in the number of cardiac surgeries & procedures and technological advancements are some factors expected to drive the market. Moreover, high incidence of cardiac diseases and availability of various surgical procedures are expected to boost the adoption of cardiac surgery instruments during the forecast period.

Technological advancements in the field of cardiac surgery instruments are considered a key driver of this market. Several key players are investing in R&D for launching innovative and novel products. Moreover, sedentary & poor lifestyle, which result in diabetes, obesity, & poor diet; smoking; and excessive alcohol consumption have also increased the predisposition to heart diseases.

Furthermore, increase in aging population and rising healthcare expenditure in emerging economies are among the factors likely to boost the number of cardiac surgeries during the forecast period. These factors are anticipated to positively influence revenue generation. According to the U.S. Census Bureau, the global healthcare spending is anticipated to increase to USD 18.28 trillion by 2040, growing at a CAGR of 2.6%. According to WHO, the world’s population aged 60 years and above is expected to reach 2 billion by 2050, from 900 million in 2015.

 Request a free sample copy or view report summary: Cardiac Surgery Instruments Market Report

Cardiac Surgery Instruments Market Report Highlights

• The forceps segment led the cardiac surgery instruments market in 2024 by product, capturing the largest revenue share of 21.15%.

• By application, the coronary artery bypass grafting segment dominated the cardiac surgery instruments market in 2024 and accounted for the largest revenue share of 31.37%.

• The hospitals segment dominated the cardiac surgery instruments market in 2024 with a revenue share of 80.97%.

• The North America cardiac surgery instruments market dominated the global market in 2024, accounting for the largest revenue share of 48.49%.

Cardiac Surgery Instruments Market Segmentation

Grand View Research has segmented the global cardiac surgery instruments market based on product, application, end use, and region:

Cardiac Surgery Instruments Product Outlook (Revenue USD Million, 2021 - 2033)

• Forceps

• Clamps

• Graspers

• Scissors

• Needle Holder

• Others

Cardiac Surgery Instruments Application Outlook (Revenue USD Million, 2021 - 2033)

• Coronary Artery Bypass Grafting

• Heart Valve Surgery

• Pediatric Cardiac Surgery

• Heart Transplant

• Others

Cardiac Surgery Instruments End Use Outlook (Revenue USD Million, 2021 - 2033)

• Hospitals

• Ambulatory Surgical Center

Cardiac Surgery Instruments Regional Outlook (Revenue USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • Spain

  • Italy

  • France

  • Denmark

  • Norway

  • Sweden

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Cardiac Surgery Instruments Market

• B. Braun Melsungen AG

• KLS Martin Group.

• Teleflex Incorporated

• Medline Industries, Inc.

• STILLE

• Sklar Corporation

• Wexler Surgical

• Murray Surgical

• Surtex Instruments Limited

• Scanlan International

• Delacroix-Chevailer

• BD